

Fundamental dimension Equity attribute | ESVNFPeer $0.08▲+0.03% Cap $521.0KP/E -1.5x QuantScore13/100 | CEGMFPeer $0.00150.00% Cap $654.4KP/E -1.7x QuantScore14/100 | GSSRFLeader $0.00370.00% Cap $249.6KP/E -36.4x QuantScore46/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
28/100 |
33/100 |
56/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 0/100 | 36/100 |
Health Piotroski, Altman Z, leverage & liquidity | 23/100 | 23/100 | 44/100 |
Growth Revenue / earnings growth & margins | 0/100 | 0/100 | 50/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -1.5x | -1.7x | -36.4x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -0.4x | — | -9.1x |
Price / Sales | 6.0x | — | — |
Price / Free Cash Flow | -0.4x | -1.5x | -14.8x |
PEG ratio | -0.00 | -0.03 | 0.01 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 3 / 9 | 0 / 9 |
Altman Z-Score | -51.92 (Distress) | -122.27 (Distress) | -50.45 (Distress) |
Total debt / equity | -0.80 | -0.71 | 0.00 |
Quick ratio | 0.4x | 0.0x | 2.1x |
Interest coverage | -15.4x | -6.8x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | — | — |
Net income growth YoY | -1092.3% | -212.1% | +102.3% |
Gross margin (TTM) | -1406.8% | 0.0% | 0.0% |
Operating margin (FY) | -4626.5% | — | — |
FCF margin (FY) | -1667.5% | — | — |
5. Trailing price performancePrice change over period |
1M return | -7.1% | 0.0% | 0.0% |
3M return | +95.2% | 0.0% | 0.0% |
6M return | -65.3% | 0.0% | -83.2% |
Year to date | -28.0% | 0.0% | -78.0% |
1Y return | -28.0% | 0.0% | +208.3% |
3Y return | +47.4% | -31.8% | -63.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.0084 -110.5% premium | $-0.0094 -728.9% premium | $0.0024 -35.3% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |